High Costs, Low Margins, and Regulatory Hurdles Hinder Pharma’s Adoption of Advanced Manufacturing Technologies

Benchmark Banner Ad

 

The ongoing drug shortage crisis in the U.S. underscores a critical need for innovation in pharmaceutical manufacturing. As manufacturing issues, outdated technologies, and geopolitical risks contribute to shortages that impact patient care and elevate healthcare costs, the introduction of Advanced Manufacturing Technologies (AMTs) offers a beacon of hope. AMT technologies promise to enhance quality control and reduce production downtime, yet their adoption in generic drug production remains low despite obvious benefits.

Why is the pharmaceutical industry slow to adopt technologies that could revolutionize drug availability and cost?

Mike Tracy, a C-Level Healthcare Operations Strategist, dives into the complexities of integrating Advanced Manufacturing Technologies in drug production. Mike points out that while AMTs can drastically reduce bottlenecks in drug production, the significant initial investment and stringent regulatory landscape pose substantial hurdles.

“Every AMT has a high startup cost and generic drugs have very razor-thin margins to begin with. We’re not talking about a new drug that’s not already out in the market where you’re going to have a high margin and it makes sense to invest millions,” Tracy explains.

Article written by Sonia Gossai

Follow us on social media for the latest updates in B2B!

Image

Latest

Rothman Index
My Mother and the Story of the Genesis of the Rothman Index – Episode 4
January 8, 2026

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risk can go unnoticed. The central challenge facing hospitals today is not…

Read More
home
Delivering Moments That Matter: The Art of Joy, Memory, and Meaning at Anthropologie Home
January 8, 2026

These days, ‘home’ means more than just four walls. It’s where people reset, gather, and express who they are—raising the bar for what they expect from the brands that help shape those spaces. Consumers are no longer just buying décor—they’re investing in meaning, memory, and moments that last. Research continues to show that people…

Read More
Texas energy
Small Margins, Big Risks: How Fraud Hurts Texas Energy Retailers
January 6, 2026

Fraud has quietly become one of the most existential threats in Texas’s deregulated retail electricity market—because the business runs on razor-thin margins and delayed payment. Under the non-POR system overseen by the Electric Reliability Council of Texas (ERCOT), retail energy providers assume the full risk of nonpayment. With profit margins often measured in just a…

Read More
learning
From 30 to 1,500 Students: Scaling Mass Experiential Learning with How to Change the World
January 5, 2026

Higher education is at a crossroads. Institutions are being asked to do more with less—serve more students, prepare them for a rapidly changing, AI-shaped workforce, and prove the real-world value of a degree—all at the same time. Employers consistently note that while graduates are technically capable, many struggle to apply what they’ve learned to…

Read More